EUVIMEDEUVIMED entdecken
Leitlinie

Indications for Hematopoietic Cell Transplantation and Immune Effector Cell Therapy: Guidelines from the American Society for Transplantation and Cellular Therapy

Abraham S Kanate, Navneet S Majhail, Bipin N Savani, Christopher Bredeson, Richard E Champlin, Stephen Crawford, Sergio A Giralt, Charles F LeMaistre, David I Marks, James L Omel, Paul J Orchard, Jeanne Palmer und 4 weitere

Biology of Blood and Marrow Transplantation · 2020-07 · 26 (7) · 1247-1256

DOI: 10.1016/j.bbmt.2020.03.002 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Biology of Blood and Marrow Transplantation, 2020-07. Verfasst von Abraham S Kanate und 15 weiteren Autor:innen. Beteiligte Einrichtung: Hematopoietic Malignancy & Cellular Therapy Program, West Virginia University, Morgantown, West Virginia. Electronic address: askanate@hsc.wvu.edu. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Lymphocytes. Die Arbeit wurde bisher 273-mal zitiert (Crossref) und nennt 78 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematopoietic Stem Cell TransplantationLymphocytesHumansReceptors, Antigen, T-CellTransplantation, AutologousTransplantation, HomologousUnited States

Stichwörter der Autor:innen

Allogeneic transplantationAutologous transplantationChimeric antigen receptor T cellsHematopoietic cell transplantationImmune effector cell therapyIndications

Substanzen

Receptors, Antigen, T-Cell

Autor:innen und Institutionen

  • Hematopoietic Malignancy & Cellular Therapy Program, West Virginia University, Morgantown, West Virginia. Electronic address: askanate@hsc.wvu.edu.
  • Blood & Marrow Transplant Program, Cleveland Clinic, Cleveland, Ohio.
  • Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Division of Hematology, University of Ottawa and Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
  • Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Cigna LifeSource Transplant Network, Pittsburgh, Pennsylvania.

Zitieren

APA

Kanate, A. S., Majhail, N. S., Savani, B. N., Bredeson, C., Champlin, R. E., Crawford, S., Giralt, S. A., LeMaistre, C. F., Marks, D. I., Omel, J. L., Orchard, P. J., Palmer, J., Saber, W., Veys, P. A., Carpenter, P. A., & Hamadani, M. (2020). Indications for Hematopoietic Cell Transplantation and Immune Effector Cell Therapy: Guidelines from the American Society for Transplantation and Cellular Therapy. Biology of Blood and Marrow Transplantation, 26(7), 1247-1256. https://doi.org/10.1016/j.bbmt.2020.03.002

Vancouver

Kanate AS, Majhail NS, Savani BN, Bredeson C, Champlin RE, Crawford S, et al. Indications for Hematopoietic Cell Transplantation and Immune Effector Cell Therapy: Guidelines from the American Society for Transplantation and Cellular Therapy. Biology of Blood and Marrow Transplantation. 2020;26(7):1247-1256. doi:10.1016/j.bbmt.2020.03.002

BibTeX
@article{Kanate2020,
  author = {Kanate, Abraham S and Majhail, Navneet S and Savani, Bipin N and Bredeson, Christopher and Champlin, Richard E and Crawford, Stephen and Giralt, Sergio A and LeMaistre, Charles F and Marks, David I and Omel, James L and Orchard, Paul J and Palmer, Jeanne and Saber, Wael and Veys, Paul A and Carpenter, Paul A and Hamadani, Mehdi},
  title = {Indications for Hematopoietic Cell Transplantation and Immune Effector Cell Therapy: Guidelines from the American Society for Transplantation and Cellular Therapy},
  journal = {Biology of Blood and Marrow Transplantation},
  year = {2020},
  volume = {26},
  number = {7},
  pages = {1247--1256},
  doi = {10.1016/j.bbmt.2020.03.002}
}
Kostenlos starten →